Search PubMed⌕ Search

Biomedical subjects

S Tajima

Publications and source records attributed to S Tajima.

At least 361 records · Page 20Linked to original sources

Analysis of a recycling-impaired mutant of low density lipoprotein receptor in familial hypercholesterolemia.

A mutant low density lipoprotein (LDL) receptor with abnormal ligand binding and recycling abilities was found in a patient with familial hypercholesterolemia. The molecular weights of the precursor and the mature form of the receptor were 72,000 and 115,000, respectively, which were about 45,000 smaller than those of the normal receptor. The mutant receptor was concluded to be present on the cell surface because the mature form was susceptible to Pronase digestion, and specific monoclonal antibody against the LDL receptor (IgG-C7) could bind to the cell surface. This mutant receptor could not bind LDL, but could bind other ligands for the LDL receptor, beta-migrating very low density lipoprotein, and the apolipoprotein E-lipid complex. After the receptor bound to the ligand, it disappeared from the cell surface of the mutant cells faster than that of normal cells, showing that, in the mutant cells, the receptor was not efficiently recycled back to the cell surface. Southern blotting of the genomic DNA from the patient showed a large deletion of about 12 kilobases around the epidermal growth factor precursor homology domain. For further characterization of the mutant, we cloned a 9.4-kilobase EcoRI/XbaI fragment, which was expected to contain the deletion joint. Mapping and sequencing analyses of the receptor gene showed that exons 7-14 were deleted. The nucleotide sequence suggested that this mutation may have occurred by recombination between repetitive Alu sequences in introns 6 and 14 of the receptor gene. The recombination brought about a complete deletion of the gene coding the epidermal growth factor precursor homology domain. The characteristics of the receptor protein produced by this mutation were similar to those of an artificial mutation constructed by Davis et al. (Davis, C. G., Goldstein, J. L., Südhof, T. C., Anderson, R. G. W., Russell, D. W., and Brown, M. S. (1987) Nature 326, 760-765) in which the whole gene coding this domain was deleted. The clinical phenotype of the patient having this mutation was similar to that of so-called "receptor-defective" type familial hypercholesterolemia, in which cells show detectable, but markedly reduced activity of the LDL receptor.

Base Sequence↗

Successful replantation of a bitten-off nose by microvascular anastomosis.

A case is presented of a nose bitten off by a dog and successfully replanted by artery-to-artery and artery-to-vein anastomosis. In the absence of vein-to-vein anastomosis, the clinical course suggested that artery-to-vein anastomosis was useful for venous drainage, although the extent to which this contributed to the survival is not known.

Animals↗

In vitro cell-free synthesis of bullous pemphigoid polypeptide.

We investigated the genetic expression of bullous pemphigoid (BP) antigen (230 kD) synthesized by Pam cells using an in vitro cell-free translation assay followed by immunoprecipitation. Prior to the study, we showed that (1) the 230 kD polypeptide does not undergo further processing after it is produced by cells in the short pulse experiment; (2) the 230 kD polypeptide is not degraded at least within the 18 h of the chase experiment; and (3) with tunicamycin treatment the underglycosylated BP antigen still interacts specifically with BP serum. The polypeptide of molecular size slightly greater than 230 kD was identified in the translated proteins directed by ribonucleic acid (RNA) isolated from Pam cells. The size of the mRNA was estimated to be approximately 34S-40S (7.7-10.9 kilobase) using the fractionation method with sucrose density gradient ultracentrifugation of RNA. These results indicate that bullous pemphigoid antigen (230 kD) is a primarily translated product, genetically expressed by Pam cells.

Animals↗

Analysis of apolipoprotein E7 (apolipoprotein E-Suita) gene from a patient with hyperlipoproteinemia.

We have isolated and analyzed apolipoprotein E7 gene from a patient with hyperlipoproteinemia. Apolipoprotein E7 (apolipoprotein E-Suita) is a variant of apolipoprotein E with four additional units of positive charge compared to apolipoprotein E3, which is the major isoform of apolipoprotein E. The heterozygous gene of apolipoprotein E7/3 from the patient was cloned into lambda phage. The cloned apolipoprotein E genes were subcloned into a murine retrovirus shuttle vector and were expressed. Two out of five clones expressed apolipoprotein E7. The analysis of the nucleotide sequence of the exon and exon-intron boundary regions has shown two G-to-A nucleotide substitutions in the 548 and 551 nucleotide positions from the 5'-end of the fourth exon. These two base substitutions change the amino acid residues -Glu-Glu- to -Lys-Lys- at the 244 and 245 positions from the amino-terminus of the mature protein, and give four additional units of positive charge to the molecule.

Apolipoprotein E3↗

Structure and expression of mouse apolipoprotein E gene.

The mouse apolipoprotein E gene was isolated from a genomic library by screening with a cDNA probe. DNA including apolipoprotein E gene plus segments 2.5 kilobases upstream and 0.3 kilobase downstream of the coding region was transfected into NIH3T3 cells. The cells expressed the same-size apolipoprotein E mRNA and protein as those produced by mouse endogenously. The nucleotide sequence of the gene plus 5' and 3' flanking regions (one kilobase each) was determined. The sequence of the mouse apoliprotein E gene was highly homologous to that of the rat gene, not only in the coding regions but also in the non-coding and intron regions. The mouse and the human apolipoprotein E genes were homologous in the 5' proximal flanking region up to about 200 nucleotides as well as in the four exons. This proximal region was highly conserved for the genes of mouse, rat and human; the relative positions of the "TATA box" and the two copies of "GC box" were identical.

Animals↗

Partial characterization of an unusual 185 kDa protein synthesized by dermal fibroblasts from patients with Marfan syndrome: identification of the protein as type IV collagen.

Production of an unusual collagenous protein was observed in culture of dermal fibroblasts from four patients with Marfan syndrome. The apparent molecular weight of the protein was about 185 kDa after reduction with 2-mercaptoethanol and 175 kDa after limited pepsin treatment. The 185 kDa protein was susceptible to the bacterial collagenase but resistant to the animal collagenase. Immunoprecipitation revealed the specific interaction of the pepsin-treated 175 kDa collagenous protein with monoclonal and polyclonal antibodies to human type IV collagen. From the patterns of CNBr peptide mapping the 185 kDa band was identified as alpha 1 (IV) chain. Type IV collagen in the skin is generally considered to be of non-fibroblastic origin. However, in "diseased" condition, dermal fibroblasts might produce type IV collagen. The clinical manifestation in relation to production of type IV collagen by cultured skin fibroblasts from Marfan patients is discussed.

Antibodies↗

Expression of the apolipoprotein E gene in a human macrophage-like cell line, THP-1.

The human monocyte-like cell line, THP-1, differentiated into macrophage-like cells on the addition of a phorbol ester, 12-O-tetradecanoyl-phorbol-13-acetate. During the course of differentiation of THP-1 cells, the level of transcripts of the apolipoprotein E gene increased. Apolipoprotein E mRNA increased by more than a hundred times compared to the level prior to differentiation. The apolipoprotein E mRNA reached the maximal level on day 2 after the addition of the phorbol ester and then gradually decreased. After the level had decreased to half the maximal value on day 4 it remained constant. The time course of apolipoprotein E secretion, which showed a peak on day 2, was parallel to that of apolipoprotein E protein synthesis. Furthermore, the time course of apolipoprotein E protein synthesis showed a similar profile to that of the apolipoprotein E transcript level. This indicates that the induction of apolipoprotein E expression by the phorbol ester is due mainly to the increase in the number of transcripts. The synthesis of apolipoprotein E protein was reduced by about 60% on treatment of the differentiated THP-1 cells with 5 micrograms/ml of lipopolysaccharide. The presence of 5 micrograms/ml of lipopolysaccharide in the medium reduced the level of apolipoprotein E mRNA by about 50%. Thus the reduction in protein synthesis was mainly explained by the decrease in the level of apolipoprotein E transcripts. This reduction in the mRNA level caused by lipopolysaccharide was not mediated by the tumor necrosis factor or interleukin 1, which are known to reduce the transcriptional and post-transcriptional activity of lipoprotein lipase in adipocytes, respectively.

Apolipoproteins E↗

Type IV collagen synthesis by cultured mouse keratinocytes (Pam cells).

The collagens synthesized by Pam cells were biochemically characterized. The collagen in the cell layers was identified as type IV collagen by immunoprecipitation with type IV collagen specific antibody. The apparent molecular weights were 180 Kd and 175 Kd, which converted to major (160 Kd) and several minor smaller fragments with pepsin treatment. The ratios of 3-hydroxyproline/4-hydroxyproline and 4-hydroxyproline/proline in the 160 Kd polypeptide were 0.11 and 1.18, respectively. The result shows that Pam cells are able to produce type IV collagen whose biochemical characteristics are similar to those from other epithelial cells. In the kinetic study, the synthesis of type IV collagen reached its maximum level rapidly on the 1st day after seeding, suggesting that type IV collagen may play a role in cell attachment and proliferation.

Animals↗

Deoxyribonucleic acid hybridization studies of Exophiala dermatitidis and Exophiala jeanselmei.

Exophiala dermatitidis and Exophiala jeanselmei share similar morphological features and have been confused with each other. To clarify the relationship between the two fungi, we conducted a deoxyribonucleic acid (DNA)-DNA hybridization study using a dot blot method. Between E. dermatitidis and E. jeanselmei, only a very low level of DNA relatedness was seen and it was confirmed that these two fungi are distinct species based on DNA similarity. Close correspondence of DNA from the isolates of E. dermatitidis was obtained, whereas the isolates of E. jeanselmei were divided into 6 groups according to their DNA similarity and a possibility was shown that E. jeanselmei is composed of genetically heterogeneous groups. The subdivision of the species E. jeanselmei by the DNA-DNA hybridization method was in agreement with serotyping exoantigens. This result suggests that DNA-DNA hybridization studies provide an excellent tool for the identification and grouping of pathogenic dematiaceous fungi.

DNA, Fungal↗

[Noninvasive evaluation of changes in stroke volume and left ventricular filling dynamics. Produced by atrioventricular interval manipulation].

To evaluate the effects of atrioventricular pacing interval on hemodynamics, we studied the changes in stroke volume and left ventricular filling dynamics in fourteen consecutive patients with implanted atrioventricular pacemakers using a Doppler echocardiographic technique. Twelve patients had sick sinus syndrome and 2 had complete atrioventricular block. Stroke volume was determined as the time-velocity integral of the pulsed Doppler recordings at the aortic annulus multiplied by the area of the aortic annulus obtained by 2-dimensional echocardiography. Left ventricular filling velocity was measured at the mitral annulus by the pulsed Doppler technique to provide the time-velocity integral of rapid filling (TVI-R) and that of atrial filling (TVI-A). No significant change in stroke volume was noted during the atrioventricular interval manipulation. TVI-R was greater with short atrioventricular intervals than that with the long atrioventricular intervals. On the contrary, TVI-A was greater with long atrioventricular intervals than that with short atrioventricular intervals. These results suggested that there is a compensatory mechanism in the left ventricular filling dynamics to keep the stroke volume constant despite the change in the atrioventricular interval. However, in patients with high atrial filling to rapid filling ratio (A/R), the stroke volume varied with change of atrioventricular interval, suggesting that the compensatory mechanism was not sufficient in such patients. We conclude that Doppler echocardiography is a useful, noninvasive technique to assess the changes in the hemodynamics produced by atrioventricular interval manipulation in patients with implanted atrioventricular pacemakers.

Adult↗

[An immunohistochemical study of normal sweat glands using an antibody to the breast cyst fluid protein (GCDFP-15)].

In this study, we applied the antibody against the molecular weight 15,000 protein purified from breast cyst fluid (GCDFP-15) to cutaneous tissue, especially to sweat glands. Breast cyst fluid was obtained by needle aspiration from patients with gross cystic disease. DEAE-cellulose column chromatography was performed and followed by SDS-polyacrylamide gel electrophoresis. Antisera against the purified protein were prepared in rabbits. We stained specimens of normal skin by the PAP method. The normal apocrine gland cells were strong positive and eccrine gland dark cells were positive. Eccrine gland clear cells were weak positive or negative. Duct cells of both glands were negative. From these observations, we suggest that this antibody is useful for detecting seromucous cells of sweat glands, including both the apocrine gland cells and eccrine dark cells in the skin.

Animals↗

Analysis of apolipoprotein E5 gene from a patient with hyperlipoproteinemia.

We have isolated and analyzed apolipoprotein E5 gene from a patient with hyperlipoproteinemia. Apolipoprotein E5 is a variant of apolipoprotein E with two additional units of positive charge and smaller apparent molecular weight than apolipoprotein E3, which is the major isoform of apolipoprotein E. The heterozygous gene of apolipoprotein E5/3 from the patient was cloned into lambda phage. The cloned apolipoprotein E genes were subcloned into a murine retrovirus shuttle vector and were expressed. One out of four clones expressed apolipoprotein E5. The analysis of the nucleotide sequence of the exons and exon-intron boundary regions has shown a G to A substitution in the 18th nucleotide from the 5'-end of the third exon. This single base substitution changes the amino acid residue Glu to Lys at the third position from the amino-terminus of the mature protein, and gives two additional units of positive charge to the molecule.

Apolipoproteins E↗

Mitogen-mediated protein phosphorylation in Werner's syndrome fibroblasts.

DNA synthesis of WF-1 fibroblasts derived from a patient with Werner's syndrome was stimulated by fetal calf serum and adult human serum but not by various mitogens including epidermal growth factor, platelet-derived growth factor (PDGF), fibroblast growth factor, insulin and 12-O-tetradecanoylphorbol-13-acetate (TPA). To clarify the cause of nonresponsiveness to these mitogens, we compared the rate of protein phosphorylation in normal fibroblasts HF-O and Werner's WF-1 cells. PDGF and TPA enhanced the phosphorylation of a Mr 80 K protein, which is known to be a substrate for protein kinase C, both in HF-O and WF-1 cells. This indicates that the pathway involving PDGF receptor, phosphatidylinositol turnover and protein kinase C activation is operational in WF-1 cells. Several species of phosphoproteins of Mr 250 K, 135 K, 110 K, 78 K and 42 K were detected in normal HF-O cells by immunoprecipitation using an anti-phosphotyrosine antibody. The same species of phosphoproteins were detected in Werner's WF-1 cells at passage 6, but only when treated with various mitogens and were not detected in WF-1 cells at passage 10 even after the PDGF- or TPA-treatment. These results suggest that the reduction of phosphorylation of these target proteins may be in part responsible for the diminished mitogenic responsiveness of Werner's fibroblasts.

Adult↗

General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 2nd communication: Effects on the circulation and the other systems.

Effects of 1-(2-ethoxyethyl)-2(4-methyl-1-homopiperazinyl)benzimidazole difumarate (KB-2413) on the circulation and the other systems were compared with those of ketotifen and chlorpheniramine. 1. Among the effects on the circulation and the respiratory system, KB-2413 as well as ketotifen and chlorpheniramine transiently inhibited respiration at 3 mg/kg i.v. and slightly decreased blood pressure in dogs. KB-2413 slightly decreased heart rate in dogs, but ketotifen slightly increased it. 2. KB-2413 at 100 mg/kg p.o. slightly decreased the volume of gastric juice in rats and dose-dependently increased biliary secretion in rats in the dose range of 10-100 mg/kg i.d. On the other hand, ketotifen and chlorpheniramine decreased biliary secretion. 3. KB-2413 inhibited the spontaneous movements of various isolated smooth muscles at a high concentration of 10(-4) g/ml. 4. The autonomic system in cats and the motor nervous system in rats were not influenced by KB-2413 at 3 mg/kg i.v. 5. The blood clotting system, blood sugar level, urine volume and urinary electrolytes in rats were not affected by KB-2413 in the dose range of 10-100 mg/kg p.o. 6. KB-2413 inhibited carrageenin-induced rat paw edema at 100 mg/kg p.o. In conclusion, KB-2413 showed a less potent effect on the circulation and the other systems than ketotifen and chlorpheniramine, and no results suggested serious side effects of KB-2413.

Animals↗